Molecular screening of patients with FGFR alterations for phase 1 (ph1) study with the selective FGFR inhibitor Debio 1347-MedSci.cn

Molecular screening of patients with FGFR alterations for phase 1 (ph1) study with the selective FGFR inhibitor Debio 1347

Iafrate, AJ; Borger, DR; Vivancos, A; Voss, M; Cleary, J; Meric-Bernstam, F; Tabernero, J; Flaherty, K; Ishii, N; Brichory, F; Tanaka, H; Pokorska-Bocci, A; Baselga, J; Nuciforo, P

CANCER RESEARCH, 2019; 79 (13):

科室
- - 订阅+
  - 更多科室
工具
服务

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Molecular screening of patients with FGFR alterations for phase 1 (ph1) study with the selective FGFR inhibitor Debio 1347

科室

工具

服务